Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug

Less than six months after cutting 20% of its employees, Vedanta Biosciences has again laid off staff. According to one affected staffer, half of the Cambridge, Massachusetts–based biotech’s workforce is being cut while most of the rest are furloughed.

Scroll to Top